GRAIL to Announce Third Quarter 2025 Financial Results
Rhea-AI Summary
GRAIL (Nasdaq: GRAL) will release its third quarter 2025 financial results after market close on Wednesday, Nov 12, 2025. Management will discuss results on a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET the same day.
GRAIL will also host Analyst Day 2025 on Tuesday, Nov 13, 2025 at its central laboratories in Research Triangle Park, NC, with the Analyst Day webcast beginning at 11:00 a.m. ET. Live webcasts and recorded replays for both events will be available in the investor relations section at investors.grail.com, and registration links are provided for the live events.
Positive
- None.
Negative
- None.
News Market Reaction 25 Alerts
On the day this news was published, GRAL declined 1.33%, reflecting a mild negative market reaction. Argus tracked a peak move of +4.3% during that session. Our momentum scanner triggered 25 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $46M from the company's valuation, bringing the market cap to $3.41B at that time.
Data tracked by StockTitan Argus on the day of publication.
Analyst Day 2025 Webcast to Begin at 11:00 a.m. ET on November 13th
Third Quarter 2025 Webcast and Conference Call Details
A link to the live webcast and recorded replay will be available at the investor relations section of GRAIL's website at investors.grail.com.
Please register for the live event at https://grail-q3-financial-results-2025.open-exchange.net/registration.
To ensure timely connection, please register for the teleconference and join the webcast at least ten minutes before the scheduled start of the call. The live webcast and recorded replay are open to all interested parties.
GRAIL Analyst Day 2025
Additionally, GRAIL will host its Analyst Day 2025 the following day, Tuesday, Nov. 13, 2025, at GRAIL's central laboratories in
The live webcast and recorded replay will be available at the investor relations section of GRAIL's website at investors.grail.com and at https://grail-analyst-day-2025.open-exchange.net/registration.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-announce-third-quarter-2025-financial-results-302598777.html
SOURCE GRAIL, Inc.
FAQ
When will GRAIL (GRAL) report third quarter 2025 results?
What time is the GRAIL Q3 2025 conference call and webcast (GRAL)?
How can investors join the GRAIL (GRAL) Q3 2025 webcast?
When and where is GRAIL Analyst Day 2025 for GRAL?
Will recordings of the GRAIL Q3 2025 results and Analyst Day be available?
Is pre-registration required for GRAIL (GRAL) teleconference and webcast?
